Ticker Scorecard - CHRS Basics Company: Coherus BioSciences, Inc. IPO Date: November 6, 2014 Sector: Healthcare Industry: Biotech Market Cap: $128.64M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 3.05% Avg Daily Range (30 D): $0.07 | 4.82% Avg Daily Range (90 D): $0.06 | 5.24% Institutional Daily Volume Avg Daily Volume: 1.09M Avg Daily Volume (30 D): 2.15M Avg Daily Volume (90 D): 3.78M Trade Size Avg Trade Size (Sh.): 148 Avg Trade Size (Sh.) (30 D): 328 Avg Trade Size (Sh.) (90 D): 344 Institutional Trades Total Inst.Trades: 3,214 Avg Inst. Trade: $1.51M Avg Inst. Trade (30 D): $1.63M Avg Inst. Trade (90 D): $1.23M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.76M Avg Closing Trade (30 D): $2.58M Avg Closing Trade (90 D): $1.68M Avg Closing Volume: 158.54K     News Jul 30, 2024 @ 5:00 PM Hepatic Tumor Clinical Trial Pipeline Experiences ... Source: Delveinsight Jun 27, 2024 @ 12:26 PM Coherus BioSciences Announces Divestiture of YUSIM... Source: Coherus BioSciences, Inc. Jun 23, 2024 @ 3:13 PM Pfizer: Seriously Undervalued At Peak Pessimism Source: ALLKA Research May 23, 2024 @ 9:51 PM Coherus Presents Preliminary Results from Phase I ... Source: Coherus BioSciences, Inc. May 9, 2024 @ 9:15 PM Coherus BioSciences (CHRS) Reports Q1 Loss, Misses... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.05 $-.09 $-.11 Diluted EPS $-.09 $-.09 $-.11 Revenue $ 304.34M $ 70.77M $ 64.98M Gross Profit $ 136.08M $ 50.03M $ 36.61M Net Income / Loss $ -.45M $ -10.75M $ -12.92M Operating Income / Loss $ -138.33M $ -6.39M $ -20.51M Cost of Revenue $ 168.26M $ 20.74M $ 28.37M Net Cash Flow $ 17.24M $ -61.74M $ -100.54M PE Ratio